Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
Public ClinicalTrials.gov record NCT00530816. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm, Phase 2 Study of Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the best overall response rate, safety and tolerability of carfilzomib in patients with relapsed or refractory multiple myeloma.
Study identification
- NCT ID
- NCT00530816
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 164 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Jan 2013 (Actual)
- Completion
- Jul 2013 (Actual)
- Last update posted
- May 2, 2017
2007 – 2013
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Scottsdale | Scottsdale | Arizona | 85259 | — |
| Tower Cancer Research Foundation | Beverly Hills | California | 90211 | — |
| Therapeutic Research Institute of Orange County | Laguna Hills | California | 92653 | — |
| Rocky Mountain Blood and Marrow Transplant Program | Denver | Colorado | 80218 | — |
| Oncology & Hematology Assoc. of W. Broward | Tamarac | Florida | 33321 | — |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | — |
| Emory University Winship Cancer Institute | Atlanta | Georgia | 404-778-5747 | — |
| Northwestern University | Chicago | Illinois | 60605 | — |
| Orchard Research | Skokie | Illinois | 60076 | — |
| University of Kentucky College of Medicine | Lexington | Kentucky | 40536-0093 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109-0936 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Hattiesburg Clinic | Hattiesburg | Mississippi | 39401 | — |
| Jackson Oncology Associates | Jackson | Mississippi | 39202 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| St. Vincent's Comprehensive Cancer Center | New York | New York | 10011 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Dayton Clinical Oncology Program | Dayton | Ohio | 45429 | — |
| Signal Point Clinical Research Center, LLC | Middletown | Ohio | 45042 | — |
| Harrington Cancer Center | Amarillo | Texas | 79106 | — |
| Texas Oncology Cancer Center | Austin | Texas | 78731 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00530816, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00530816 live on ClinicalTrials.gov.